Available as needed after regular office hours | Hours of Operation: Monday – Friday: 8:00 AM – 6:00 PM

Regulatory Compliance

Navigating regulatory compliance in the medical device industry is a complex and ongoing challenge. Regulatory bodies around the world, including the U.S. FDA, European Union MDR, and others, enforce strict standards to ensure patient safety and product efficacy. Non-compliance can result in costly delays, penalties, or even market withdrawal. At Global RQC Med Dev Consulting Solutions, we provide specialized regulatory compliance services designed to help manufacturers navigate this intricate landscape, avoid costly mistakes, and ensure that medical devices remain in compliance throughout their lifecycle.
Our expert team offers a broad range of services, from remediation of regulatory findings to helping you meet the requirements of both global and local regulatory frameworks. With years of experience and in-depth knowledge of industry regulations, we are your trusted partner in compliance, helping you achieve your goals while adhering to the highest standards.

Remediation Strategies (483 Findings, NB Findings, Mock Audit Preparation)

During FDA or Notified Body inspections, non-conformities can lead to findings such as FDA Form 483 observations or Notified Body (NB) findings. These documents highlight deficiencies in your processes or product compliance and must be addressed to avoid further regulatory actions, such as product recalls, bans, or penalties. Addressing these findings is critical for maintaining your device’s marketability and protecting your reputation.

At Global RQC, we offer targeted remediation strategies to help companies respond to and resolve findings quickly. Our remediation services begin with a comprehensive analysis of the FDA 483 or NB findings, followed by the development of a detailed action plan to address the issues. We work closely with your team to implement corrective and preventive actions (CAPA), ensuring that your processes comply with industry standards and regulatory requirements.
Furthermore, we help prepare for audits with mock audit preparation. Mock audits simulate real regulatory inspections, enabling your company to identify potential weaknesses in your compliance systems. By proactively preparing for audits, we minimize the risk of receiving findings and help streamline the audit process, ultimately reducing the likelihood of non-compliance.

Regulation (EU) 2017/745: European Medical Device Regulation (MDR)

The European Union Medical Device Regulation (EU MDR 2017/745) establishes the requirements for the marketing and use of medical devices in Europe. As of May 2021, all medical devices marketed in the EU must comply with MDR, which replaced the EU’s Medical Devices Directive (MDD). The MDR places a stronger emphasis on clinical evaluation, post-market surveillance, and device traceability, creating stricter regulations for manufacturers.

Global RQC provides expert assistance in ensuring compliance with the EU MDR. Our services include:

  • Gap analysis: We assess your existing systems and practices to identify gaps in compliance with the MDR. We work with your team to implement corrective actions to address these gaps before they become regulatory issues.
  • Clinical evaluation: The MDR requires comprehensive clinical evidence to support the safety and efficacy of medical devices. We assist in clinical trial design, data analysis, and ensuring your clinical evaluations meet MDR requirements.
  • Post-market surveillance: Post-market surveillance (PMS) is a critical part of the MDR, ensuring that devices continue to meet safety standards after they are marketed. Our team helps design and implement PMS plans that comply with MDR standards, ensuring that you maintain oversight over your device’s lifecycle.
  • UDI (Unique Device Identifier): The MDR mandates that devices must be identified through a UDI system, which enhances traceability and reporting. We guide you in implementing UDI compliance to facilitate smooth device traceability across the supply chain.

Navigating the complexities of MDR requires expertise, and our team is here to ensure that your products meet the latest regulatory requirements in Europe, protecting both your market access and patient safety.

Corrective and Preventive Action (CAPA)

A robust Corrective and Preventive Action (CAPA) system is fundamental to maintaining regulatory compliance and ensuring continuous product quality. CAPA systems are designed to address non-conformities, investigate root causes, and prevent the recurrence of issues in the future. Both the FDA’s QSR 820 and ISO 13485 require that medical device manufacturers establish and maintain effective CAPA systems.

Global RQC offers comprehensive support in the development and implementation of CAPA systems, including:

  • Non-conformity identification: We help you identify non-conformities through various methods such as internal audits, customer complaints, and inspections.
  • Root cause analysis: Using techniques like the 5 Whys or Fishbone Diagram, we conduct root cause analyses to uncover the underlying issues that lead to non-conformities.
  • Corrective actions: Once the root cause is identified, we assist in implementing corrective actions that resolve the immediate issues. This may include process changes, retraining, or improvements to manufacturing controls.
  • Preventive actions: To prevent recurrence, we help you develop preventive measures and integrate them into your quality management system (QMS).

By implementing a strong CAPA system, we help you ensure that non-conformities are not just addressed but prevented, reducing the likelihood of regulatory issues and improving product quality.

Audits (FDA, QSR 820, & ISO 13485 Audits)

Audits play a vital role in ensuring ongoing regulatory compliance for medical device manufacturers. These audits are conducted by regulatory bodies such as the FDA or Notified Bodies, as well as third-party organizations, and they help evaluate whether your operations meet the required regulatory standards. In addition, regular internal audits help identify areas for improvement, reducing risks and ensuring continual compliance.

Global RQC provides end-to-end audit services, including:

  • Pre-audit preparation: We help prepare your documentation, systems, and procedures for upcoming audits. This includes conducting internal audits and gap analysis to ensure readiness and resolve any issues before the official audit takes place.
  • Audit execution: During the audit, we act as your liaison with auditors, providing detailed explanations of your processes and documentation. Our team ensures that the audit runs smoothly and that you are fully prepared to address any questions from the auditors.
  • Post-audit support: After the audit, we work with you to address any findings, implementing corrective actions and ensuring that your systems remain compliant. Our goal is to help you maintain a continuous state of audit readiness.

We ensure that your business is always prepared for regulatory audits, minimizing disruptions and preventing compliance gaps that could delay approvals or lead to penalties.

At Global RQC Med Dev Consulting Solutions, we understand the critical importance of regulatory compliance in the medical device industry. With our extensive experience and expert knowledge, we are dedicated to helping you navigate complex regulatory environments. Whether you’re addressing remediation findings, developing a robust CAPA system, or preparing for audits, our team is here to ensure your medical devices remain in compliance and your business remains competitive. Contact us today to learn more about how our Regulatory Compliance services can help you meet industry standards, mitigate risks, and achieve business success.

FREQUENTLY ASKED QUESTIONS

A QMS is a structured system of processes and procedures aimed at ensuring consistent product quality, regulatory compliance, and continuous improvement in the production and delivery of medical devices.

ISO 13485:2016 ensures that manufacturers consistently produce safe and effective medical devices. Certification to this standard helps companies demonstrate their commitment to quality and regulatory compliance.

QSR 820 outlines the requirements for medical device manufacturers in the U.S. to implement a quality system that ensures product safety and effectiveness. It affects all aspects of manufacturing, including design, testing, and post-market activities.

Implementing a QMS involves designing processes, creating documentation, training staff, and ensuring compliance with industry standards. We help businesses tailor their QMS to meet specific needs while ensuring regulatory compliance.

A gap analysis identifies deficiencies between your current QMS and regulatory requirements or best practices. This helps prioritize corrective actions to address areas of non-compliance and reduce risks.

Preparation involves reviewing and updating your QMS to ensure it meets FDA requirements. Our team provides support by conducting audits, training your staff, and ensuring your documentation is audit-ready.

ISO 13485 covers the requirements for design, production, and post-market surveillance of medical devices. Key components include risk management, CAPA, documentation control, and continuous improvement.

Yes, we offer end-to-end support for ISO 13485 certification, from implementing a compliant QMS to preparing for the certification audit and providing post-certification support.

Corrective and Preventive Actions (CAPA) are critical for identifying, investigating, and resolving issues that could affect product quality or safety. CAPA helps prevent recurring problems and ensures continuous improvement.

OUR PARTNERS & CLIENTS

WE ARE PROUD MEMBERS OF

CONTACT US

Global RQC Med Device Consulting Solutions, LLC.

We are providing regulatory and quality consulting services to the medical device industry. Navigation and streamlining the global regulatory arena!

Our Address :
Phone No :
Working hours :